| Accession |
PRJCA014807 |
| Title |
SHR-A1921-I-101-An open, multicenter phase I clinical study on the safety, tolerance, pharmacokinetics and efficacy of SHR-A1921 for injection in patients with advanced malignant tumors |
| Relevance |
Medical |
| Data types |
Clinical, imaging, metabolic data, etc
|
| Organisms |
Homo sapiens
|
| Description |
SHR-A1921-I-101-An open, multicenter phase I clinical study on the safety, tolerance, pharmacokinetics and efficacy of SHR-A1921 for injection in patients with advanced malignant tumors |
| Sample scope |
Multiisolate |
| Release date |
2023-02-07 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
weiqing ge
weiqing
ge (weiqing.ge@hengrui.com)
|
| Organization |
Jiangsu Hengrui pharmaceutical Co.LTD |
| Submission date |
2023-02-07 |
